<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230812059131N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-24</date_registration>
      <primary_sponsor>Neurology research center of Imam khomeini hospital</primary_sponsor>
      <public_title>Effect of auricular vagus nerve stimulation on sleep</public_title>
      <acronym></acronym>
      <scientific_title>Effect of auricular vagus nerve stimulation on total sleep time, sleep quality, insomnia severity and sleep log in primary insomnia patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>25</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72385</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, allocation will be done into two groups of intervention and control. The tool of allocation will be "www.sealed envelope.com" and the ratio of allocation is 1:1. The type of allocation is complete (simple) and the unit of allocation is  each patient, Blinding description: Both patients and people who follow up the patients and retrieve their data, are blinded regarding the patient's intervention. In order to achieve this, the researcher who explains the patient how to use the device and knows the location of electrode and the group of each patient (control or  intervention), does not cooperate in any of the future steps of the study like follow ups or data analysis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary Insomnia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, patients in intervention group receive electric stimulation in concha region of the ear (enervated by Vagus nerve). One electrode is placed in left ear concha in the form of a clip and the other one is placed behind the shoulder in the form of a pad. Intervention 2: Control group: In this study, patients in control receive electric stimulation in earlobe region of the ear (non-enervated by Vagus nerve). One electrode is placed in left ear concha in the form of a clip and the other one is placed behind the shoulder in the form of a pad.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Publishing the results of the study in the form of medical doctor thesis and a study in international journals

When:
After the defense session of the thesis

To whom:
For general population

Conditions:
Other researchers

Where to obtain:
Arian Hasani
Address: No 19, First alley, Northern Naft St, Mirdamad, Tehran, Iran
Email address: a-Hasani@student.tums.ac.ir
Emergent number: +989390348543

Hamed Amiri fard
Address: Neurology building, Northern door of Imam Khomeini hospital, Eastern Bagher khan St, Chamran highway, Tehran, Iran
Email address: dr.amirifard@gmail.com
Emergent number: 02161192053

How to obtain:
After confirmation by the responsible authorities

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Arian Hasani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 19, first alley, northern Naft St, mirdamad Blvd, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1761835411</zip>
        <telephone>+98 21 3660 1419</telephone>
        <email>a-Hasani@student.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arian Hasani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 19, first alley, northern Naft St, mirdamad Blvd, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1761835411</zip>
        <telephone>+98 21 3660 1419</telephone>
        <email>a-Hasani@student.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 18 and 70
Being right-handed
Being diagnosed as primary insomnia with at least one out of three symptoms of primary insomnia (1.problem with falling asleep, 2problem with maintaining sleep, 3.sleep deprivation) for at least 3 months
PSQI sleep quality equal or more than 7</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of head injury
Nervous system disorder
Drug abuse
Critical primary disease in endocrine system, cardiovascular system, blood and psychiatry
Having contraindications for taVNS intervention like asthma and cardiac arrhythmias
Use of hypnotic drugs
Use of psychiatric drugs
Pregnancy or lactation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F51.01</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>A condition of unsatisfactory quantity and/or quality of sleep, which persists for a considerable period of time, including difficulty falling asleep, difficulty staying asleep, or early final wakening. Insomnia is a common symptom of many mental and phys</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, patients in intervention group receive electric stimulation in concha region of the ear (enervated by Vagus nerve). One electrode is placed in left ear concha in the form of a clip and the other one is placed behind the shoulder in the form of a pad.</i_keyword>
      <i_keyword>Control group: In this study, patients in control receive electric stimulation in earlobe region of the ear (non-enervated by Vagus nerve). One electrode is placed in left ear concha in the form of a clip and the other one is placed behind the shoulder in the form of a pad.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Duration of sleep. Timepoint: Measuring sleep duration from the beginning till the end of the intervention (everyday for a month). Method of measurement: sleep log chart.</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: Measured in the beginning and the end of the study (beginning and end of the one month duration of the intervention). Method of measurement: Pittsburgh Sleep Quality Index (PSQI) questionary.</prim_outcome>
      <prim_outcome>Insomnia severity. Timepoint: Measured in the beginning and the end of the study (beginning and end of the one month duration of the intervention). Method of measurement: Insomnia severity index (ISI).</prim_outcome>
      <prim_outcome>Fatigue severity. Timepoint: Measured in the beginning and the end of the study (beginning and end of the one month duration of the intervention). Method of measurement: Epworth sleepiness scale (ESS).</prim_outcome>
      <prim_outcome>Depression severity. Timepoint: Measured in the beginning and the end of the study (beginning and end of the one month duration of the intervention). Method of measurement: Hamilton Rating Scale for Depression (HAMD).</prim_outcome>
      <prim_outcome>Anxiety severity. Timepoint: Measured in the beginning and the end of the study (beginning and end of the one month duration of the intervention). Method of measurement: Hamilton Rating Scale for Anxiety (HAMA).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Neurology research center of Imam khomeini hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-11</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Room 604, sixth floor, central building of Tehran university of medical sciences, Keshavarz Blvd, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
